Stephen Berenson

Insider Reports History

Location
Cambridge, MA
Signature
/s/ Thomas J. DesRosier, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Stephen Berenson:

Company Role Class Num Shares Value Price $ Report Date Ownership
Moderna, Inc. Director Common Stock 22,203 $2,517,789 $113.40 03 May 2024 Direct
Moderna, Inc. Director Restricted Stock Units 0 $0 $113.40 03 May 2024 Direct
Seres Therapeutics, Inc. Director Stock Option (right to buy) 11,470 01 Jul 2025 Direct
Moderna, Inc. Director Stock Option (Right to Buy) 7,557 06 May 2024 Direct

Insider Reports Filed by Stephen Berenson

Symbol Company Period Transactions Value $ Form Type Role Filing Time
MCRB Seres Therapeutics, Inc. 01 Jul 2025 1 $0 4 Director 02 Jul 2025, 17:38
MCRB Seres Therapeutics, Inc. 10 Apr 2025 1 $0 4 Director 11 Apr 2025, 16:05
MCRB Seres Therapeutics, Inc. 01 Jul 2024 1 $0 4 Director 03 Jul 2024, 16:15
MRNA Moderna, Inc. 03 May 2024 3 $0 4 Director 07 May 2024, 17:10
MCRB Seres Therapeutics, Inc. 04 Apr 2024 1 $0 4 Director 08 Apr 2024, 16:45
MCRB Seres Therapeutics, Inc. 22 Jun 2023 1 $0 4 Director 23 Jun 2023, 17:25
MRNA Moderna, Inc. 03 May 2023 2 $0 4 Director 05 May 2023, 16:10
MRNA Moderna, Inc. 28 Apr 2023 2 $0 4 Director 01 May 2023, 17:32
MCRB Seres Therapeutics, Inc. 22 Jun 2022 1 $0 4 Director 24 Jun 2022, 16:30
MRNA Moderna, Inc. 28 Apr 2022 4 $0 4 Director 02 May 2022, 16:47
MRNA Moderna, Inc. 19 Aug 2021 1 $0 4 Director 20 Aug 2021, 16:17
MCRB Seres Therapeutics, Inc. 16 Jun 2021 1 $0 4 Director 21 Jun 2021, 16:30